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Evidence suggests the bactericidal activity of mito-
chondria-derived reactive oxygen species (mROS)
directly contributes to killing phagocytozed bacteria.
Infection-responsive components that regulate
this process remain incompletely understood. We
describe a role for the mitochondria-localizing
enzyme encoded by Immunoresponsive gene 1
(IRG1) during the utilization of fatty acids as a fuel
for oxidative phosphorylation (OXPHOS) and associ-
ated mROS production. In a zebrafish infection
model, infection-responsive expression of zebrafish
irg1 is specific to macrophage-lineage cells and is
regulated cooperatively by glucocorticoid and JAK/
STAT signaling pathways. Irg1-depleted macro-
phage-lineage cells are impaired in their ability
to utilize fatty acids as an energy substrate for
OXPHOS-derived mROS production resulting in
defective bactericidal activity. Additionally, the
requirement for fatty acid b-oxidation during infec-
tion-responsive mROS production and bactericidal
activity toward intracellular bacteria is conserved in
murine macrophages. These results reveal IRG1
as a key component of the immunometabolism
axis, connecting infection, cellular metabolism, and
macrophage effector function.
INTRODUCTION
The emerging field of immunometabolism has its basis in the
observation that inflammation is a ‘‘hallmark’’ of many chronic
metabolic disorders (Mathis and Shoelson, 2011). Central to
this link between the immune andmetabolic systems is the mito-
chondrion. In addition to roles during cellular metabolism and
apoptosis, mitochondria are becoming recognized as central
players in the orchestration of inflammatory pathways and im-
mune cell function (Manfredi and Rovere-Querini, 2010; West
et al., 2011b). Studies have linked the production of mitochon-
drial reactive oxygen species (mROS), a byproduct of oxidative
phosphorylation (OXPHOS), and macrophage-mediated bacte-Celricidal activity (Sonoda et al., 2007; West et al., 2011a). In an
active process, mitochondria are recruited to phagosomes con-
taining phagocytozed bacteria to deliver OXPHOS-generated
bactericidal ROS (West et al., 2011a). How mitochondrial meta-
bolism influences immune cell function, and what signaling
cascades help drive cell-intrinsic metabolic modes in immune
cells, is incompletely understood and an area of intense interest.
Identified as an LPS-inducible gene within macrophages,
immunoresponsive gene 1 (IRG1) is highly conserved in verte-
brates, suggesting an important role during the immune
response (Lee et al., 1995). IRG1 is the mammalian ortholog of
bacterial 2-methylcitrate dehydratase (encoded by the prpD
gene), an enzyme that functions during catabolism of the
short-chain fatty acid propionate (propanoate/propionic acid).
In light of this, and given that IRG1 localizes to the mitochondria,
we reasoned that IRG1 may represent a key component linking
immunological and metabolic processes (Degrandi et al., 2009).
The zebrafish is a well-established model in which to study
innate immune cell function. By 2 days postfertilization (dpf),
zebrafish embryos are populated with macrophage lineages
that are functionally similar to those in humans. Live imaging
macrophage-lineage-specific transgenic zebrafish has enabled
unique insights into their innate immune cell function (Ellett
et al., 2011; Roca and Ramakrishnan, 2013). More recently,
live imaging of fluorescent fatty acid analogs within transparent
zebrafish embryos and larvae has given researchers the ability
to directly observe their cellular metabolism, resulting in new
mechanistic insights into lipid metabolism (Carten et al., 2011;
Semova et al., 2012). Most of our understanding regardingmeta-
bolic modes of immune cells has been gleaned from in vitro cell
culture-based studies. The live imaging potential of the geneti-
cally tractable zebrafish system provides a unique opportunity
to directly observe how the metabolic mode of immune cells
influences their activity in the context of an intact cellular
environment.
Exploiting the zebrafish system, we have examined the func-
tional role of the zebrafish ortholog of IRG1 (Irg1) during the
innate immune cell response to bacterial infection. We show
that zebrafish irg1 is rapidly expressed within macrophage-line-
age cells in response to bacterial infection. We further reveal that
infection-responsive expression of irg1 is dependent on the
‘‘primary response’’ transcription factor C/ebpb and the cooper-
ative activity of the glucocorticoid receptor (GR) and JAK/
STAT signaling pathways. Mitochondria of Irg1-depletedl Metabolism 18, 265–278, August 6, 2013 ª2013 Elsevier Inc. 265
Figure 1. Macrophage-Lineage Cells Express irg1 in Response to Infection
(A) Temporal QPCRanalysis of irg1 expressionwithin infected larvae (relative to PBS-injected controls) throughout first hour of infection, n = 3 biological replicates
(mean ± SD).
(B and C) Expression of irg1within PBS-injected control and infected larvae at 1 hpi, respectively. Arrow marks hindbrain ventricle injection site. Inset, magnified
view of boxed region of similarly treated larva (103 objective).
(D) Quantification of irg1+ cells within individual infected larvae at 10, 20, 30, 40, 50, and 60 mpi (mean ± SD).
(E and F) Expression of irg1 within infected larvae at 6 and 24 hpi, respectively.
(G–I) Dual expression analysis of irg1 and mpeg1 (G), apoeb (H), and lyz (I) within the midbrain/hindbrain region of infected larvae at 24 hpi.
(J and K) Expression of irg1 within infected control MO-injected and Irf8-depleted larvae, respectively, at 1 hpi.
(L) Quantification of irg1+ cells within individual infected larvae as shown in (J) and (K) (mean ± SD). All views anterior to left. Numbers represent frequency of larvae
with displayed phenotype. Scale bar, 100 mm in (B). ****p < 0.0001. See also Figure S1.
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Irg1 and Macrophage Functionmacrophage-lineage cells are deficient in their ability to utilize
fatty acids as an energy substrate for mitochondrial OXPHOS
andmROS production, resulting in decreased bactericidal activ-
ity. We also reveal a conserved dependence on fatty acid
b-oxidation for mROS production and bactericidal activity within
stimulated murine macrophages. We propose that IRG1 func-
tions within the mitochondria of activated macrophage-lineage
cells to enhance the utilization of ‘‘energetically efficient’’ fatty
acid b-oxidation. The resulting increase in OXPHOS amplifies
mROS production that helps augment macrophage bactericidal
activity toward intracellular bacteria. These results reveal IRG1
as a key component of the immunometabolism axis connecting
infection, mitochondrial metabolism, and macrophage effector
function.266 Cell Metabolism 18, 265–278, August 6, 2013 ª2013 Elsevier IncRESULTS
Zebrafish irg1 Is Expressedwithin Macrophage-Lineage
Cells in Response to Infection
We first identified the zebrafish ortholog of human IRG1 as a
gene upregulated in response to Salmonella enterica serovar
Typhimurium (hereafter referred to as Salmonella) infection using
the GeneChip Zebrafish Genome Array (Affymetrix) (data not
shown). Quantitative (q)PCR analysis of irg1 expression in
response to Salmonella (600 colony-forming units [cfu] injected
into the hindbrain ventricle at 52 hpf) revealed elevated ex-
pression as early as 30 min postinjection (mpi), when com-
pared with PBS control-injected larvae (Figure 1A). Of note,
uninjected and PBS control-injected larvae demonstrated no.
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study, unless otherwise stated, an infection dose of 600 cfu of
Salmonella was microinjected into the hindbrain ventricle at 52
hpf. From 40 mpi, irg1-expressing cells were increasingly de-
tected throughout the trunk and tail vasculature and within the
midbrain and hindbrain of infected larvae (Figures 1C and 1D).
From 6 hr postinjection (hpi), expression became restricted to
themidbrain and hindbrain (Figures 1E and 1F). Expression anal-
ysis revealed that irg1-expressing cells were also positive for the
macrophage-lineagemarkermpeg1 andmicroglial marker apoli-
poprotein Eb (apoeb) but not the neutrophil-specific marker lyso-
zyme C (lyz), consistent with a macrophage-lineage phenotype
(Figures 1G–1I). In zebrafish larvae, microglia differentiate from
macrophages that have invaded the developing brain from
60 hpf (Herbomel et al., 2001). In light of this, throughout the
remainder of this study we refer to irg1- and mpeg1-expressing
cells within the midbrain and hindbrain region as macrophage-
lineage cells. Irf8 promotes macrophage lineage commitment
at the expense of neutrophil development such that Irf8-deficient
larvae are depleted of macrophage-lineage cells and possess an
expanded neutrophil compartment (Li et al., 2011). In support of
irg1 expression being restricted to macrophage-lineage cells,
infection-responsive irg1 expression was completely abolished
within morpholino oligonucleotide (MO)-mediated Irf8-depleted
larvae (Figures 1J–1L and see Figures S1A–S1E online). In addi-
tion to live bacterial challenge, injection of Toll-like receptor (TLR)
ligands, in particular lipopolysaccharide (LPS) and flagellin, stim-
ulated irg1 expression (Figures S1F and S1G). Consistent with
previous studies, infection-responsive expression of irg1 was
not dependent on the TLR adaptor MyD88 (Kawai et al., 2001;
van der Vaart et al., 2013) (Figures S1H–S1K).
These results demonstrate that irg1 expression is rapidly
inducedwithinmacrophage-lineage cells in response to live bac-
terial challenge and TLR agonist stimulation.
Expression of irg1 Is Dependent upon the Infection-
Responsive Primary Response Gene cebpb
Due to the rapid kinetics of irg1 expression in response to infec-
tion, we assessed whether expression was dependent on de
novo protein synthesis. Larvae treated with cycloheximide
(CHX) demonstrated an almost complete inhibition of infection-
responsive irg1 expression (Figures 2A–2C). This result
confirmed that irg1 is a ‘‘secondary response’’ gene within acti-
vated macrophage-lineage cells that likely relies upon infection-
responsive (‘‘primary response’’) regulators for transcriptional
activation. Analysis of the promoter region of irg1 revealed a
number of consensus binding motifs for the transcription factor
C/EBPb (Figure S2A). C/EBPb is a known transcriptional regu-
lator of the acute phase response, where it functions as a primary
response gene (Matsuno et al., 1996). Similar to irg1, cebpb was
expressed in cells throughout the trunk vasculature following
infection (Figure 2D). Of note, constitutive expression of cebpb
was observedwithin the developing liver and intestine of PBS-in-
jected control larvae (Figure 2D). However, unlike irg1, infection-
responsive cebpb expression was maintained in the presence of
CHX, confirming its classification as a primary response gene
within activated macrophage-lineage cells (Figure 2D). Of inter-
est, CHX treatment of infected and PBS-injected larvae resulted
in elevated expression of cebpb when compared with DMSO-Celtreated larvae (Figure 2D), raising the possibility that expression
of cebpb is, in part, controlled via a transcriptional repressor.
Consistent with this result, primary response genes have been
shown to be uniquely associated with corepressor complexes
to prevent signal-independent missexpression (Hargreaves
et al., 2009). We anticipate this is a mechanism to suppress
infection-independent missexpression of cebpb and its target
genes. Expression analysis revealed infection-responsive
expression of cebpb colocalized with irg1+ macrophage-lineage
cells within themidbrain and hindbrain (Figure 2E) and circulation
(Figure 2F). Examining cebpb expression within infected Irf8-
depleted larvae further supported infection-responsive expres-
sion of cebpb as being macrophage-lineage specific (Figures
2G and 2H). Assessing irg1 expression within infected C/ebpb-
depleted larvae revealed that, despite maintaining typical
numbers of macrophage-lineage cells (Figure S2B), irg1 expres-
sion was almost completely abolished (Figures 2I–2K). Further
support for the genetic positioning of Irg1 downstream of C/
ebpb was provided by showing infection-responsive cebpb
expression to be independent of Irg1 (Figures S2C–S2E).
These results reveal that the primary-response transcription
factor C/ebpb helps drive infection-responsive irg1 expression
within macrophage-lineage cells (Figure 2L). Of note, ectopic
delivery of cebpb mRNAs into zebrafish embryos (that we have
previously shown can drive ectopic expression of target genes
[Hall et al., 2012]) did not result in irg1 missexpression (data
not shown), suggesting that, although required, C/ebpb is not
sufficient to drive irg1 expression. C/ebpb-driven expression of
irg1 is most likely dependent on cooperation with other infec-
tion-responsive transcriptional regulators.
Glucocorticoid Receptor Signaling Promotes irg1
Expression through Its Direct Regulation of cebpb
Expression
Analysis of the promoter region of zebrafish cebpb revealed
several consensus glucocorticoid (GC) response elements
(GREs) (Figure S3A). Importantly, GC has been demonstrated
to induce C/EBPb expression within minutes of stimulation,
independent of new protein synthesis (Hazra et al., 2007). We
investigated whether the rapid onset of irg1 expression within
stimulated macrophage-lineage cells was dependent upon
GC-driven expression of cebpb.
To assess the requirement for endogenous GR-mediated
signaling during infection-responsive irg1 expression, infected
larvae were treated with the GR antagonist RU-486 and irg1
expression examined. RU-486-treated infected larvae demon-
strated a dose-dependent reduction in the number of irg1+ cells,
when compared with infected DMSO-treated controls (Figures
3A–3C). Depleting larvae of the zebrafish ortholog of NR3C1
(encoding the GR) resulted in a similar reduction of irg1 expres-
sion in response to infection (Figures 3D–3F and Figure S3B).
Nr3c1 depletion also resulted in reduced infection-responsive
cebpb expression within macrophage-lineage cells (Figures 3G
and 3H). Of note, Nr3c1-depleted larvae maintained typical
numbers of macrophage-lineage cells (Figure S2B). Following
infection, Nr3c1 protein was detected in the nucleus of macro-
phage-lineage cells (Figure 3I). The stress response of mammals
is in part mediated through the production of endogenous GC by
the adrenal gland. In zebrafish, the interrenal tissue functions asl Metabolism 18, 265–278, August 6, 2013 ª2013 Elsevier Inc. 267
Figure 2. Infection-Responsive Expression of irg1 within Macrophage-Lineage Cells Is Dependent on the Primary Response Transcription
Factor C/ebpb
(A and B) Expression of irg1 within infected DMSO (control)- and CHX-treated larvae, respectively, at 1 hpi.
(C) Quantification of irg1+ cells within individual infected larvae as shown in (A) and (B) (mean ± SD).
(D) Expression of cebpb within DMSO (control)- and CHX-treated larvae, following infection or PBS injection, at 1 hpi.
(E and F) Dual expression analysis of irg1 and cebpb within the midbrain/hindbrain and trunk, respectively, of infected larvae at 24 hpi.
(G and H) Expression of cebpb within infected control MO-injected and Irf8-depleted larvae, respectively, at 1 hpi.
(I and J) Expression of irg1 within infected control MO-injected and C/ebpb-depleted larvae, respectively, at 1 hpi.
(K) Quantification of irg1+ cells within individual infected larvae as shown in (I) and (J) (mean ± SD).
(L) Schematic illustrating proposed regulation of infection-responsive irg1 expression within macrophage-lineage cells. Asterisks, arrows, and arrowheads mark
blood-specific, liver-specific, and gut-specific cebpb expression, respectively. All views anterior to left. Numbers represent frequency of larvae with displayed
phenotype. Scale bar, 100 mm in (A). Abbreviations: DA, dorsal aorta; PCV, posterior cardinal vein; ****p < 0.0001. See also Figure S2.
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esis (Liu, 2007). Interrenal cells within embryos can be
specifically ablated through knockdown of Nr5a1a (Liu, 2007).
In addition to depleting larvae of functional markers of steroido-
genesis (such as cyp11a1), Nr5a1a-depleted larvae also demon-
strated marked reduction of irg1+ cells following infection,
despite maintaining typical numbers of macrophage-lineage268 Cell Metabolism 18, 265–278, August 6, 2013 ª2013 Elsevier Inccells (Figures S2B and S3C–S3G). To investigate whether exog-
enously supplied GR agonists were sufficient to induce cebpb
and irg1, dexamethasone, hydrocortisone, or prednisolone
was injected into the hindbrain ventricle of 2 dpf larvae and
cebpb or irg1 expression examined. In contrast to irg1, cebpb
expression within macrophage-lineage cells was strongly
induced in response to GR agonist injection (Figures 3J and 3K)..
Figure 3. Glucocorticoid Receptor-Medi-
ated Signaling Helps Regulate Infection-
Responsive irg1 Expression within
Macrophage-Lineage Cells through Induc-
tion of cebpb Expression
(A and B) Expression of irg1 within infected DMSO
(control)- and RU-486-treated (250 mM) larvae,
respectively, at 1 hpi.
(C) Quantification of irg1+ cells within individual
infected larvae treated with DMSO (control),
125 mM RU-486, or 250 mM RU-486 (mean ± SD).
(D and E) Expression of irg1within infected control
MO-injected and Nr3c1-depleted larvae, respec-
tively, at 1 hpi.
(F) Quantification of irg1+ cells within individual
larvae as shown in (D) and (E) (mean ± SD).
(G and H) Expression of cebpb within infected
control MO-injected and Nr3c1-depleted larvae,
respectively, at 1 hpi.
(I) Immunofluorescence detection of Nr3c1 (Alexa
546) and Mpeg1/EGFP (Alexa 488) within DAPI-
stained infected macrophage-lineage marking
Tg(mpeg1:EGFP) larvae at 1 hpi. Dashed line
marks Nr3c1+ nucleus.
(J) Expression of irg1 and cebpb within dexa-
methasone-, hydrocortisone-, and prednisolone-
injected larvae at 2 hpi.
(K) Quantification of irg1+ cells within individual
larvae as shown in (J) (mean ± SD).
(L) Schematic illustrating proposed regulation of
infection-responsive irg1 expression within
macrophage-lineage cells. Asterisks, arrows, and
arrowheads mark blood-specific, liver-specific,
and gut-specific cebpb expression, respectively.
All views anterior to left. Numbers represent fre-
quency of larvae with displayed phenotype. Scale
bar, 100 mm in (A). Abbreviations: ***p < 0.001;
****p < 0.0001; n.s., not significant. See also
Figure S3.
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control infection-responsive cebpb expression within macro-
phage-lineage cells and that additional infection/stress-respon-
sive pathways contribute to irg1 expression (Figure 3L).
The JAK/STAT Pathway Cooperates with GR Signaling
to Regulate irg1 Expression in Response to Infection
Given the synergistic regulation of acute phase proteins by
members of the C/EBP and cytokine-responsive STAT transcrip-
tion factor families (Arambasic et al., 2010; Kordula and Travis,
1996), we investigated whether the JAK/STAT pathway contrib-
utes to irg1 expression.
Analysis of the promoter region of zebrafish irg1 revealed a
number of STAT consensus binding motifs (Figure S4A). In
addition, qPCR analysis of cytokine expression levels following
infection revealed a number to be rapidly expressed with
similar temporal kinetics to that of irg1 (Figure S4B). To examineCell Metabolism 18, 265–27a requirement for JAK/STAT signaling
during infection-responsive irg1 ex-
pression, we utilized the cell-permeable
JAK inhibitor AG490 and the STAT3-
specific inhibitor (STAT3 inhibitorpeptide/PpYLKTK-mts) (Funakoshi-Tago et al., 2011; Turkson
et al., 2001). Both AG490- and STAT3 inhibitor-treated larvae
demonstrated a dose-dependent decrease in the number of
irg1+ cells following infection, compared to DMSO-treated con-
trols (Figures 4A–4D). A similar reduction in the number of irg1+
cells was observed within infected Stat3-depleted larvae,
despite maintaining typical numbers of macrophage-lineage
cells, when compared to controls (Figures 4E–4G and Fig-
ure S2B). This was in contrast to infection-responsive cebpb
expression that remained unaffected following Stat3 depletion
(Figures 4H and 4I). In addition, phosphorylated Stat3, as
detected by immunofluorescence, was only observed within
macrophage-lineage cells following infection (Figures 4J–4L).
Consistent with the cooperative activities of GR- and JAK/
STAT-mediated signaling on irg1 expression, depletion of both
Stat3 and Nr3c1 had a cumulative effect on reducing infection-
responsive irg1 expression (Figures 4M–4O).8, August 6, 2013 ª2013 Elsevier Inc. 269
(legend on next page)
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Irg1 and Macrophage FunctionThese data show that infection-responsive irg1 expression
within macrophage-lineage cells requires both the GR and
JAK/STAT signaling pathways (Figure 4P).
Irg1-Depleted Macrophage-Lineage Cells Demonstrate
Reduced Bacterial Activity
In support of a bactericidal activity for macrophage-lineage
cells in our infection system, Irf8-depleted larvae were highly
susceptible to even a low-dose infection challenge, when
compared with controls (Figure S1E). To address whether
Irg1 contributes to this bactericidal macrophage activity, we
monitored bacterial persistence within Irg1-depleted larvae
infected with GFP-expressing Salmonella (hereafter referred
to as Sal-GFP). Irg1-depleted larvae demonstrated a significant
increase in bacterial persistence, as assessed by live fluores-
cence microscopy (Figures 5A and 5B) and CFU counts/
infected larva (Figure 5C), when compared with control larvae.
This enhanced persistence was associated with a decrease in
survival postinfection (Figure 5D). We next live imaged the
intracellular bacterial burden within individual macrophage-
lineage cells marked within Tg(mpeg1:mCherry) larvae (Ellett
et al., 2011) following Sal-GFP injection (measured as the
volume of GFP fluorescence signal within Mpeg1:mCherry+
cells). This revealed that Irg1-depleted macrophage-lineage
cells contained significantly elevated bacterial loads, when
compared to controls, suggesting a defect in bactericidal
activity (Figures 5E–5G). Of note, Irg1-depleted infected larvae
maintained similar numbers of macrophage-lineage cells within
the midbrain/hindbrain injection region, as measured at 3 hpi,
when compared to control MO-injected infected larvae (Figures
S5A–S5C).
A recent study has demonstrated the ability to directly
observe and measure the bactericidal activity of fluorescent
neutrophils infected with Mycobacterium marinum (Mm) by
live imaging infected zebrafish larvae (Yang et al., 2012). By
measuring the change in intracellular bacterial burden of
red fluorescent Mm (quantified as a volume of intracellular
fluorescence signal) within individual tracked green fluorescent
neutrophils over time, a ‘‘killing rate’’ (Dmm3/min) was calcu-
lated (Yang et al., 2012). We performed a similar analysis to
track infected macrophage-lineage cells following Sal-GFPFigure 4. JAK/STAT Pathway Cooperates with Glucocorticoid Recepto
sion within Macrophage-Lineage Cells
(A–C) Expression of irg1 within infected DMSO (control)-, AG490 (0.5 mM)-, and
(D) Quantification of irg1+ cells within individual infected larvae treated with DMSO
(mean ± SD).
(E and F) Expression of irg1 within infected control MO-injected and Stat3-deple
(G) Quantification of irg1+ cells within individual infected larvae as shown in (E) a
(H and I) Expression of cebpb within infected control MO-injected and Stat3-dep
(J and K) Immunofluorescence detection of phosphorylated Stat3 (Stat3-P, Alexa
injected and infected Tg(mpeg1:EGFP) larvae, respectively, at 1 hpi. Yellow aste
(L) Quantification of Stat3-P+ macrophage-lineage cells within the midbrain/hind
assessed, 100 mm from dorsal-most surface of midbrain/hindbrain (512 3 512, 5
(M and N) Expression of irg1 within infected control MO-injected and Stat3 + Nr3
(O) Quantification of irg1+ cells within individual infected control MO-injected, S
(mean ± SD).
(P) Schematic illustrating proposed regulation of infection-responsive irg1 expres
blood-specific, liver-specific, and gut-specific cebpb expression, respectively. A
phenotype. Scale bar, 100 mm in (A). ****p < 0.0001. See also Figure S4.
Celinjection into Irg1-depleted and control MO-injected
Tg(mpeg1:mCherry) larvae. This revealed that Irg1-depleted
macrophage-lineage cells were defective in killing phagocy-
tozed Sal-GFP, when compared to controls (Figures 5H
and 5I).
These results confirm that enhanced susceptibility of
Irg1-depleted larvae to infection is, at least in part, the result of
reduced Irg1-dependent bactericidal activity of macrophage-
lineage cells.
Irg1-Depleted Macrophage-Lineage Cells Demonstrate
Defective Mitochondrial ROS Production in Response to
Infection
Mitochondria have been shown to actively recruit to phago-
somes containing phagocytozed bacteria where elevated
mROS production enhances ROS-mediated bacterial killing
(West et al., 2011a). Live imaging Sal-GFP-infected macro-
phage-lineage cells within Tg(mpeg1:mCherry) larvae coinjected
with the mitochondria-marking MitoTracker probe revealed
similar clustering ofmitochondria around phagocytozed bacteria
(Figures S6A–S6C). In light of the mitochondrial localization of
IRG1 (Degrandi et al., 2009), we investigated a potential role
for Irg1 during mROS production.
To directly observe and quantify mROS, we took advantage of
the MitoSOX red mitochondrial superoxide indicator that specif-
ically detects ROS produced within mitochondria. Coinjection of
Salmonella with MitoTracker and MitoSOX probes into macro-
phage-lineage marking Tg(mpeg1:EGFP) larvae (Ellett et al.,
2011) confirmed that MitoSOX fluorescence was specific to
the mitochondria (Figures 6A and 6B). Quantifying mROS pro-
duction as the total fluorescence intensity within individual
macrophage-lineage cells within MitoSOX/Salmonella-coin-
jected Tg(mpeg1:EGFP) larvae revealed a significant increase
in mROS when compared to MitoSOX/PBS-injected controls
(Figures 6C and 6E). Similar analysis within Irg1-depleted larvae
confirmed that infection-responsive mROS production was Irg1
dependent (Figures 6D and 6E) and could be partially rescued
following irg1 overexpression (Figure 6E and Figures S6D and
S6E). These results confirm that macrophage-lineage mROS is
generated in response to infection through an Irg1-dependent
mechanism.r-Mediated Signaling to Regulate Infection-Responsive irg1 Expres-
STAT3 inhibitor peptide (62.5 mM)-treated larvae, respectively, at 1 hpi.
, AG490 (0.5 and 1.0mM), or STAT3 inhibitor peptide (62.5 and 125 mM), at 1 hpi
ted larvae, respectively, at 1 hpi.
nd (F) (mean ± SD).
leted larvae, respectively, at 1 hpi.
568) andMpeg1/EGFP (Alexa 488) within themidbrain/hindbrain region of PBS-
risks mark macrophage-lineage cells containing phosphorylated Stat3.
brain region of individual larvae as shown in (J) and (K) (mean ± SD). Region
0 z sections at 2 mm).
c1-depleted larvae, respectively, at 1 hpi.
tat3-depleted, Nr3c1-depleted, and Stat3 + Nr3c1-depleted larvae, at 1 hpi
sion within macrophage-lineage cells. Asterisks, arrows, and arrowheads mark
ll views anterior to left. Numbers represent frequency of larvae with displayed
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Figure 5. Irg1-Depleted Macrophage-Lineage Cells Demonstrate Diminished Bactericidal Activity
(A and B) Live imaging of control MO-injected and Irg1-depleted larvae, respectively, following infection with Sal-GFP, imaged at 1 dpi.
(C) CFU counts of remaining Sal-GFP within individual infected control MO-injected and Irg1-depleted larvae quantified at 8 and 24 hpi (mean ± SD).
(D) Survival graph demonstrating percentage survival of control MO-injected PBS-injected, Irg1-depleted PBS-injected, control MO-injected infected, and Irg1-
depleted infected larvae from 1 to 5 dpi.
(E and F) Live confocal imaging of Sal-GFP within macrophage-lineage cells (within the midbrain/hindbrain region) of control MO-injected and Irg1-depleted
Tg(mpeg1:mCherry) larvae, at 3 hpi, respectively.
(G) Quantification of intracellular Sal-GFP burden within individual macrophage-lineage cells as shown in (E) and (F) (measured as total intracellular volume of
Sal-GFP per mpeg1+ cell, mean ± SD).
(H) Representative frames from live time-lapse confocal imaging of Sal-GFP infected macrophage-lineage cells within the midbrain/hindbrain region of control
MO-injected and Irg1-depleted larvae (imaging starts at 3 hpi). White arrows mark tracked infected macrophage-lineage cell. Intracellular bacterial volume within
tracked cells is displayed as mm3 within each time point.
(I) Quantification of killing rate (change in Sal-GFP bacterial volume/time, Dmm3/min) of tracked infected macrophage-lineage cells, as shown in (H) (mean ± SD).
Scale bars, 200 mm in (A); 5 mm in (E). *p < 0.05; ****p < 0.0001. See also Figure S5.
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Irg1 and Macrophage FunctionIrg1-Dependent Mitochondrial ROS Production in
Response to Infection Is Dependent on Fatty Acid
b-Oxidation
Immune cells have the capacity to fuel OXPHOS through glycol-
ysis or fatty acid b-oxidation to support cell function (Pearce and
Pearce, 2013). To determine whether infection-responsive
mROS production within macrophage-lineage cells was depen-
dent upon either glucose or fatty acid catabolism, we examined
mROS production in the presence of chemical inhibitors of
glycolysis and b-oxidation.
Treatment with the glycolysis inhibitor 2-deoxy-d-glucose
(2-DG) (Suganuma et al., 2010) resulted in no significant
decrease in mROS production (Figures 6F, 6G, and 6I). This
was in contrast to treatment with etomoxir, an inhibitor of carni-
tine palmitoyltransferase-1 (Cpt1) (Vickers, 2009), a rate-limiting
enzyme essential for b-oxidation, which inhibitedmROS produc-
tion in a dose-dependent manner (Figures 6F, 6H, and 6I). To
assess the contribution of b-oxidation to the inflammatory
response, etomoxir was coinjected with Sal-GFP, followed by
analysis of bacterial persistence and larval survival. Etomoxir
treatment effected a dose-dependent reduction in the ability of
infected larvae to clear microinjected bacteria, when compared
with DMSO-treated controls (Figures S6F and S6G). This
bacterial persistence was associated with a decrease in survival
postinfection (Figure S6H), similar to that observed within Irg1-
depleted larvae (Figures 5A–5D).
These results suggest that during infection themitochondria of
macrophage-lineage cells employ b-oxidation to fuel mito-
chondrial respiration and the resulting production of Irg1-depen-
dent mROS.
Mitochondria of Stimulated Macrophage-Lineage Cells
Demonstrate Enhanced Fatty Acid Uptake
To investigate whether macrophage-lineage cells enhance their
uptake of fatty acids to fuel mROS production in response to
infection, we investigated the subcellular distribution of fluores-
cent fatty acids within LPS-stimulated macrophage-lineage
cells. The fluorescent fatty acid analog BODIPY FL C16 has pre-
viously been used to image fatty acid uptake, accumulation, and
transport in both human cells and live zebrafish larvae (Carten
et al., 2011; Thumser and Storch, 2007).
To live image subcellular accumulation of BODIPY FL C16, we
took advantage of its ability to shift fluorescence emission from
green to red when detected at concentrations sufficient to
induce excimer formation (Carten et al., 2011). Confocal imaging
using a ratio channel (red/green) then enabled areas of highly
concentrated BODIPY FL C16 to be live imaged. Following coin-
jection of BODIPY FL C16, LPS, and MitoTracker into the hind-
brain ventricle, we detected subcellular regions of highly
concentrated BODIPY FL C16 within macrophage-lineage cells
(as detected bymorphology) (Figure S7A). Line intensity profiling
confirmed that areas of maximum BODIPY FL C16 concentration
were localized to the mitochondria (Figures S7A and S7B).
Measuring peak fluorescence intensity ratios within individual
macrophage-lineage cells following coinjection of BODIPY FL
C16 with LPS or PBS showed BODIPY FL C16 only concentrated
within the mitochondria of LPS-stimulated macrophage-lineage
cells (Figures S7C, S7D, and S7G). Transportation of fatty acids
across the outer mitochondrial membrane into the mitochondrialCelmatrix is regulated by the rate-limiting enzyme Cpt1. Repeating
the above experiment in the presence of coinjected etomoxir
demonstrated that LPS-stimulated trafficking of BODIPY FL
C16 into the mitochondria was dependent on Cpt1-mediated
transport (Figures S7E–S7G).
Fatty Acid Supplementation Can Enhance Macrophage-
Lineage mROS Production in Response to Infection, but
Not Following Irg1 Depletion
We next evaluated whether exogenously supplied fatty acids
could enhance the production ofmROSwithinmacrophage-line-
age cells. Coinjecting an equimolar mixture of several saturated
fatty acids with Salmonella resulted in elevated production of
mROS within macrophage-lineage cells, when compared with
Salmonella injection alone (Figures 7A–7C). A similar increase
was not detected within Irg1-depleted larvae (Figure 7C). Micro-
injection of exogenous fatty acids also enhanced the clearance
of coinjected Sal-GFP, when compared with Sal-GFP injection
alone (Figures S7H–S7J). Of note, overexpression of irg1 was
not sufficient to elevate mROS within macrophage-lineage cells,
even following fatty acid supplementation (Figure S7K).
These data show that exogenously supplied fatty acids can
enhance the production of infection-responsive mROS within
macrophage-lineage cells and the clearance of injected
bacteria. Furthermore, the utilization of exogenous fatty acids
to enhance mROS requires Irg1.
LPS-Induced Mitochondrial ROS Production and
Bactericidal Activity within Murine Macrophages Are
Dependent on Fatty Acid b-Oxidation
We next investigated whether b-oxidation-dependent mROS
production was conserved within stimulated mammalian macro-
phages and whether it contributed to bactericidal activity.
Consistent with our studies in zebrafish larvae, etomoxir-treated
J774.2 cells were defective in mROS production (in response to
LPS) and bactericidal activity toward intracellular Sal-GFP (Fig-
ures 7D–7F). Importantly, these effects of etomoxir were not
the result of a general/nonspecific impairment of cell health or
immune response, as evidenced by unaffected elevated expres-
sion of Irg1 and the proinflammatory cytokines TNF-a and
IL-12p40 (Figure S7L). Of note, stimulation of J774.2 cells with
LPS resulted in elevated Irg1 expression (Figure S7M) and the
detection of IRG1 protein at the mitochondria (Figure S7N).
DISCUSSION
Taking advantage of live imaging techniques within an intact
animal model system, we reveal Irg1 as a critical component of
the immunometabolism axis connecting infection, mitochondrial
metabolism, and macrophage function. We show that expres-
sion of Irg1, an infection-responsive enzyme known to localize
to the mitochondria, is dependent on the cooperative activities
of both the GR and JAK/STAT signaling pathways and the
transcription factors C/ebpb and Stat3. We further reveal Irg1
to be essential for infection-responsivemROS production, a pro-
cess dependent on enhanced mitochondrial uptake and
b-oxidation of fatty acids. Defective mROS and its associated
bactericidal activity contribute to impaired bacterial clearance
by Irg1-deficient macrophage-lineage cells (Figure 7G). Wel Metabolism 18, 265–278, August 6, 2013 ª2013 Elsevier Inc. 273
Figure 6. mROS Production within Macrophage-Lineage Cells Is Dependent on Irg1 and Fatty Acid b-Oxidation
(A) Live confocal imaging of mROS production by macrophage-lineage cells within the midbrain/hindbrain region of Tg(mpeg1:EGFP) larvae at 3 hpi (following
injection of Salmonella (Sal.), MitoSOX, and MitoTracker mitochondria-marking probes).
(B) Line intensity profiles for MitoSOX and MitoTracker (for line shown in A) demonstrating overlapping signals and specificity of MitoSOX to the mitochondria of
macrophage-lineage cells.
(legend continued on next page)
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b-oxidation for mROS production and bactericidal activity within
stimulated murine macrophages.
It has long been recognized that professional phagocytes pro-
duce ROS as part of their effector response to help eliminate
intracellular bacteria. These intracellular bactericidal ROS were
primarily believed to result from the activity of phagosomal
superoxide-generating NADPH oxidases (NOX) (Rada and
Leto, 2008). It is now apparent that mROS production, a conse-
quence of electron transport through OXPHOS complexes and a
major source of cellular ROS, increases following infection and
directly contributes to clearing bacteria from infected macro-
phages (Roca and Ramakrishnan, 2013; West et al., 2011a,
2011b). Mitochondria have been shown to associate with phag-
osomes containing intracellular bacteria (Chong et al., 2009;
Sinai et al., 1997). In an important study, West and colleagues
demonstrate that the consequence of this mitochondrial traf-
ficking is to deliver bactericidal ROS into the phagosome to
enhance the clearance of intracellular bacteria (West et al.,
2011a). The authors propose this mROS bactericidal contribu-
tion acts in concert with NOX-derived ROS to effect full ROS
generation within the phagosome (West et al., 2011a). Our live
imaging data support this emerging role formROS in contributing
to the clearing of intracellular bacteria within infected macro-
phages. We show that both zebrafish and murine macrophages
utilize fatty acids to ‘‘fuel’’ mROS production that contributes to
the clearance of intracellular bacteria. We demonstrate that this
mROS production is dependent on infection-responsive expres-
sion of the mitochondria-localizing enzyme Irg1, which is also
required for the utilization of fatty acids as a fuel to help augment
mROS production. Our data show that Irg1, although required, is
not sufficient to drive mROS production in the absence of infec-
tion, even in the presence of enhanced fatty acid availability. This
suggests that Irg1 acts in concert with other infection-responsive
metabolic machinery to facilitate the utilization of fatty acids dur-
ing b-oxidation-driven mROS production.
The infection-responsive capacity of mitochondria to poten-
tiate OXPHOS-derived mROS production suggests they
possess enhanced OXPHOS capacity, either through elevated
mitochondrial biogenesis and/or upregulated production/activity
of OXPHOS components. Macrophage activation by interferon-
g has been demonstrated to enhance expression of several
OXPHOS components through activation of estrogen-related
receptor-a (ERRa) and peroxisome proliferator-activated
receptor-g co-activator 1b (PGC1b) (Sonoda et al., 2007). This
signaling cascade contributes to increased mROS production
and the efficient clearance of intracellular Listeria monocyto-(C and D) Live confocal imaging of mROS production bymacrophage-lineage cells
Tg(mpeg1:EGFP) larvae at 3 hpi, respectively, following Salmonella and MitoSO
warmer colors representing higher signal intensities.
(E) Quantification of mROS production by macrophage-lineage cells (measured a
marked in (C), within control MO-injected and Irg1-depleted Tg(mpeg1:EGFP) la
rescue experiment, 300 pg irg1 mRNA was coinjected with Irg1-targeting MOs.
(F) Schematic illustrating glucose and fatty acids as alternate energy sources for m
2-DG (glycolysis inhibitor) and the b-oxidation inhibitor etomoxir (specific for Cp
(G and H) Live confocal imaging of mROS production by macrophage-lineage c
following Salmonella (Sal.)/MitoSOX injection supplemented with 500 mM of 2-DG
(I) Quantification of mROS production by macrophage-lineage cells (as measured
sampled per treatment. Scale bar, 5 mm in (A). Abbreviations: n.s., not significan
Celgenes, linking inflammation-responsive elevation in macrophage
mitochondrial respiratory capacity with mROS and bactericidal
activity. The potential of cytokines to influence mitochondrial
respiratory capacity has also been demonstrated within lympho-
cytes following infection. Interleukin-15-stimulated memory
CD8+ T cells possess considerable spare respiratory capacity
(the capacity to generate extra ATP through OXPHOS to satisfy
elevated energy demands) associated with increased mitochon-
drial biogenesis and enhanced fatty acid b-oxidation (van der
Windt et al., 2012).
A master regulator of b-oxidation in the liver is the GC-respon-
sive transcriptional coactivator PGC-1a. In support of GC and
C/EBPb as upstream regulators of Irg1, and the involvement of
Irg1 during enhanced fatty acid catabolism, the activities of
murine PGC-1a, Cpt1a (a PGC-1a target), and long-chain acyl-
coenzyme A dehydrogenase (LDAC), all critical regulators of
b-oxidation, have been shown to be C/EBPb dependent within
the regenerating liver (Wang et al., 2008). IRG1 has been
described as the mammalian homolog of bacterial 2-methylci-
trate dehydratase (Chen et al., 2003). This enzyme catalyzes a
critical step during short-chain fatty acid metabolism in bacteria,
to help fuel the TCA cycle (Brock et al., 2002). Recently it has
been shown that Irg1 can catalyze production of itaconic acid,
which possesses bactericidal activity (Michelucci et al., 2013).
How the enzymatic activity of Irg1 (or downstream metabolites
it may generate) is biochemically implicated during b-oxida-
tion-driven mROS production is the focus of future research.
We propose that IRG1 functions as a critical regulator of
macrophage function by helping regulate an increase in b-oxida-
tion-‘‘fueled’’ mROS production. In the context of bacterial infec-
tion, this mROS augments macrophage bactericidal capacity.
However, as a signaling molecule, mROS can also influence
effector function by altering the production and activity of
different inflammatory cytokines (Naik and Dixit, 2011). Given
the growing importance of mROS during the pathogenesis of
conditions with an underlying inflammatory component, in-
cluding diabetes, cancer, and neurodegenerative diseases,
identifying new signaling systems that modulate its production
holds therapeutic promise. IRG1 therefore represents a




Tg(UAS-E1b:Kaede)s1999t (herein referred to as Tg[mpeg1:Gal4/UAS:kaede]),within themidbrain/hindbrain region of control MO-injected and Irg1-depleted
X injection. MitoSOX fluorescence intensity is displayed as a colormap, with
s total fluorescence intensities of MitoSOX within individual mpeg1+ cells), as
rvae at 3 hpi, following PBS or Salmonella (Sal.) injection (mean ± SD). For the
Five to ten larvae were sampled per treatment.
itochondrial respiration and associatedmROS production. Points of activity for
t1) are marked.
ells within the midbrain/hindbrain region of Tg(mpeg1:EGFP) larvae at 3 hpi,
and etomoxir, respectively.
in G and H) following indicated treatments (mean ± SD). Five to ten larvae were
t; *p < 0.05; ***p < 0.001; ****p < 0.0001. See also Figure S6.
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Figure 7. Irg1 Is Required for Enhanced mROS Production within Macrophage-Lineage Cells in Response to Fatty Acid Supplementation
Inhibition of b-oxidation reduces LPS-stimulated mROS production and bactericidal activity of J774.2 murine macrophage-like cells.
(A and B) Live confocal imaging of mROS production by macrophage-lineage cells within the midbrain/hindbrain region of control MO-injected Tg(mpeg1:EGFP)
larvae, at 3 hpi, following Salmonella (Sal.)/MitoSOX injection alone or supplemented with an equimolar fatty acid mixture, respectively. MitoSOX fluorescence
intensity is displayed as a colormap, with warmer colors representing higher signal intensities.
(legend continued on next page)
Cell Metabolism
Irg1 and Macrophage Function
276 Cell Metabolism 18, 265–278, August 6, 2013 ª2013 Elsevier Inc.
Cell Metabolism
Irg1 and Macrophage Functionand Tg(mpeg1:EGFP)gl22 transgenic zebrafish (Danio rerio) were used in this
study. Research was conductedwith approval from The University of Auckland
Animal Ethics Committee.
Infection of Zebrafish Larvae
Larvae were injected with wild-type or GFP-expressing Salmonella serovar
Typhimurium into the hindbrain ventricle as previously described (Hall et al.,
2012).
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridizations were performed as previously described
(Hall et al., 2012; Jowett and Lettice, 1994). To quantify irg1-expressing cells,
larvae were mounted and viewed under Nomaski optics (103 objective) on a
Leica DMRBE compound microscope.
RT-PCR
Total RNAs were extracted from embryos and larvae using TRIzol reagent
(Invitrogen) and cDNAs generated using Superscript III reverse transcriptase
(Invitrogen). Gene-specific amplicons were generated using the primer pairs
listed in Table S1.
Morpholino Oligonucleotide Injection
Efficacious doses for all MOs (Gene Tools, Philomath, OR) were determined
empirically. RT-PCR was used to determine MO specificity where splice-
blocking MOs were used (see Table S2 for oligonucleotide sequences and
doses).
Confocal Imaging
Live embryos and larvae were imaged as previously described (Hall et al.,
2009b; Yang et al., 2012). Imageswere processed and analyzed using Volocity
6.1.1 (Perkin Elmer). See Table S3 for live imaging dyes/fluorescent probes
used, their concentrations, and excitation/emission maxima.
Chemical Treatments
See Table S4 for drugs used, their targets, treatment doses, and mode of
delivery. No abnormal development or toxicity was observed for all com-
pounds used at the indicated working concentrations.
Quantitative PCR
QPCR was performed with Platinum SYBR Green qPCR SuperMix-UDG with
ROX (Invitrogen) using an ABI PRISM 7900HT Fast sequence detection system
(Applied Biosystems). Gene-specific oligonucleotides were designed using
Primer Express software (see Table S1).
Statistical Analysis
Statistical analyses were performed using Prism 5.0 (GraphPad Software,
Inc.). Statistical significance was assessed using unpaired, two-tailed t tests,
and all data presented in scatter plots are mean ± SD. p values < 0.05 were
considered statistically significant.
Immunofluorescence
Primary and secondary antibodies used are listed in Table S5.
Flow Cytometry
Flow cytometry was performed as previously described (Hall et al., 2009a).(C) Quantification of mROS production by macrophage-lineage cells (measured
marked in (A) and (B), within control MO-injected and Irg1-depleted Tg(mpeg1:EG
larvae were sampled for each treatment.
(D) Quantification of MitoSOX fluorescence, as detected by flow cytometry (mea
cells treated with LPS alone (500 ng/ml) or supplemented with 50 mM etomoxir,
(E) Gentamicin protection assay showing infected DAPI-stained J774.2 cells (e
postinfection (hpi) with Sal-GFP.
(F) Quantification of recovered Sal-GFP following cell lysis and plating of sample
(G) Model for Irg1/b-oxidation-dependent bactericidal mROS production. Sca
***p < 0.001; ****p < 0.0001. See also Figure S7.
CelPromoter Analysis
Putative transcription factor binding sites were identified using Genomatrix
MatInspector software.
TLR and GR Agonist Injections
TLR (Human TLR Agonist Kit, InvivoGen) and GR agonists were injected into
the hindbrain ventricle at 52 hpf. See Table S6 for microinjection doses. All ag-
onists were diluted in filter-sterilized PBS.
Fatty Acid Injections
An equimolar ratio of fatty acids (Table S7) wasmicroinjected into the hindbrain
ventricle at 52 hpf.
Cell Culture and Gentamicin Protection Assay
J774.2 murine macrophage-like cells were maintained in RPMI 1640 (GIBCO,
Life Technologies) supplemented with 10% fetal bovine serum and 5%
antibiotic-antimycotic (GIBCO, Life Technologies). The gentamicin protection
assay was performed essentially as described (West et al., 2011a).
Refer to the Supplemental Information for detailed experimental
procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, seven tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at http://dx.doi.org/10.1016/j.cmet.2013.06.018.
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